
HC30: Changes in patients’ experiences
Patients versus medical professionals
While patients experience cancer treatment as a unique life-changing series of events, to medical professionals it constitutes routine work practice.
Joanna Baines
Joanna Baines wrote an article containing 3 stories of 3 generations of breast cancer:
- Grandmother
- Stayed at home after diagnosis, died at the age of 56
- For her, cancer was an experience of silence
- Mother
- Was diagnosed with breast cancer at 35
- Treatment
- Radical mastectomy
- Removal of the entire breast, nipple, lymph nodes, vessels and muscles → severe and mutilating operation
- Became less and less popular throughout the 1970s
- Ovarian ablation throughout radiotherapy
- 5 year follow up of remaining breast and glands
- Radical mastectomy
- Hardly received any information about her condition → saw cancer as an event
- Joanna Baines
- Diagnosed with breast cancer at 32 years old
- Received several supplementary tests
- Abdomen
- Liver
- Bones
- Treatment
- Removal of the lump and lymph nodes in the armpit
- Chemotherapy (5 months)
- Radiotherapy
- Tamoxifen (5 years)
- Herceptin
- She was part of an RCT (randomized control trial)
- Saw cancer as a part of her life
Timeline
A timeline of emerging cancer therapies has been created:
- 1850-1920: radical surgery
- 1900-1950: radiation
- Major alternative to surgery before chemotherapy
- High energy radiation equipment
- Huge machine surrounding the patient
- Emerged in the early 20th century
- 1950-1970: chemotherapy
- Emerged after the WWII
- 3 types
- Nitrogen mustards
- Discovered during WWII
- Don’t produce lasting remission
- Hormones
- Increased use in the 1940s-1950s
- Now regarded as palliative
- Tamoxifen became available in the 1970s-1980s
- Antimetabolites
- Sydney Farber diagnosed ALL in a 2-year-old and injected him with aminopterin (an antifolic) → worked very well
- Nitrogen mustards
- Didn’t become the cure that everyone had hoped → only prolonged the lives for several months
- Issues
- Drug resistance
- Death due to new complications
- Survival isn’t worthwhile
- Many experiments where done in the 1960s
- 1970-1990: combination therapy
- Dr. Pinkel made a breakthrough by combining high dose chemotherapy and radiation
- More toxic chemicals
- Radiotherapy in the brain and chemotherapy in the spinal fluid
- Double doses in case of no success
- “Total therapy” → a total hell for patients
- Even though there was a huge therapeutic optimism, there were several problems
- Toxicity, response, life impact and trauma, complications, drug resistance, etc.
- Ethical dilemmas in research of cancer treatment
- 1978: cisplatin was introduced
- Highly effective
- Many toxic effects → kidney failure later on
- Dr. Pinkel made a breakthrough by combining high dose chemotherapy and radiation
Join with a free account for more service, or become a member for full access to exclusives and extra support of WorldSupporter >>
Mechanisms of Disease 2 2020/2021 UL
- Mechanisms of Disease 2 HC2: Cancer genetics
- Mechanisms of Disease 2 HC3: Cancer biology
- Mechanisms of disease 2 HC4: Cancer etiology
- Mechanisms of disease 2 HC5: Hereditary aspects of cancer
- Mechanisms of Disease 2 HC6: Cancer and genome integrity
- Mechanisms of Disease 2 HC7: Clinical relevance of genetic repair mechanisms
- Mechanisms of Disease 2 HC8: General principles: diagnostic pathology
- Mechanisms of Disease 2 HC9: Nomenclature and grading of cancer
- Mechanisms of Disease 2 HC10: General principles: metastasis
- Mechanisms of Disease 2 HC11: General principles: molecular diagnostics
- Mechanisms of Disease 2 HC12: How did cancer become the emperor of all maladies?
- Mechanisms of Disease 2 HC13: Heterogeneity in cancer
- Mechanisms of Disease 2 HC14: Cancer immunity and immunotherapy
- Mechanisms of Disease 2 HC15: Framework oncology and staging
- Mechanisms of Disease 2 HC16+17: Pharmacology I&II
- Mechanisms of Disease 2 HC18: Biomarkers for early detection of cancer
- Mechanisms of Disease 2 HC19: Surgical oncology
- Mechanisms of Disease 2 HC20: Radiation oncology
- Mechanisms of Disease 2 HC21: Medical oncology
- Mechanisms of Disease 2 HC22: Chemoradiation
- Mechanisms of Disease 2 HC23: Normal hematopoiesis
- Mechanisms of Disease 2 HC24: Diagnostics in hematology
- Mechanisms of Disease 2 HC25: Myeloid malignancies
- Mechanisms of Disease 2 HC26: Malignant lymphomas
- Mechanisms of Disease 2 HC27+28: Allogenic stem cell transplantation and donor lymphocyte infusion I&II
- Mechanisms of Disease 2 HC29: HLA & minor histocompatibility antigens
- Mechanisms of Disease 2 HC30: Changes in patients’ experiences
- Mechanisms of Disease 2 HC31: Targeted therapy and hematological malignancies
- Mechanisms of Disease 2 HC32+33: Primary hemostasis
- Mechanisms of Disease 2 HC34+35: Secondary hemostasis I&II
- Mechanism of Disease 2 HC36: Fibrinolysis and atherothrombosis
- Mechanisms of Disease 2 HC37: Cancer, coagulation and thrombosis
- Mechanisms of Disease 2 HC38: Bleeding disorders
- Mechanisms of Disease 2 HC39: Thrombosis

Contributions: posts
Spotlight: topics
Mechanisms of Disease 2 2020/2021 UL
Deze bundel bevat uitwerkingen van alle hoorcolleges, patientdemonstraties en eventuele (proef)tentamens van het blok Mechanisms of Disease 2 van de studie Geneeskunde aan de universiteit Leiden.
JoHo can really use your help! Check out the various student jobs here that match your studies, improve your competencies, strengthen your CV and contribute to a more tolerant world
Add new contribution